Serum concentrations of Erlotinib at a dose of 25 mg daily.
Costa
Daniel B
DB
Kobayashi
Susumu
S
Yeo
Wee-Lee
WL
Hamada
Akinobu
A
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000188:drug therapy / Q000235:genetics; D002851:Chromatography, High Pressure Liquid; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D047428:Protein Kinase Inhibitors / Q000097:blood* / Q000627:therapeutic use; D011799:Quinazolines / Q000097:blood* / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors